strange???

GSK have stated that they have sold 600m pounds of Relenza since the outbreak of the swine flu virus so that's:

600m divided by .56 to convert to Australian dollars by 7% for BTA share = about $75m less the about $9m paid last quarter that comes to about $66m.

Now I have used rough figures but if GSK report around $40m for this quarter then BTA will rocket.

That does not included the Lani deal or the 11c dividend.

I bought some more today left the computer after lunch as Tuesday is my special grandson and I walk day so put in a bid for $3.10 and did not expect to get them but got them easily wow $2.88 hey.

Let see what tommorrow brings but one thing is sure after the GSK quarterly results on the 28/10/09 then we should have a big jump.

I do own BTA and obviously biased so DYOR.